Overview


According to FutureWise analysis the market for anaphylaxis treatment in 2023 is US$ 3.16 billion, and is expected to reach US$ 6.26 billion by 2031 at a CAGR of 8.90%.

Anaphylaxis is a serious and possibly life-threatening allergic reaction that happens quickly after being exposed to an allergen, which is a substance that sets off an immune response in people who are sensitive to it. This hypersensitive immune reaction involves the release of various chemicals, particularly histamine, from immune cells, leading to a cascade of symptoms that can affect multiple systems within the body. Anaphylaxis is characterized by its sudden onset and can escalate swiftly, demanding immediate medical attention.

Anaphylaxis symptoms may differ in their intensity, but often entail skin reactions like hives and itching, as well as respiratory symptoms like shortness of breath, wheezing, and throat constriction. Cardiovascular symptoms may manifest as a rapid or irregular heartbeat, low blood pressure, and fainting. Possible gastrointestinal symptoms include nausea, vomiting, and abdominal pain, which can become life-threatening if left untreated. Therefore, prompt treatment is necessary to prevent a dangerous situation from arising. The cornerstone of anaphylaxis treatment is the administration of epinephrine, a hormone that rapidly counteracts the allergic response. Epinephrine works by constricting blood vessels, which helps reverse the drop in blood pressure, and by relaxing the airway muscles, allowing for improved breathing. Immediate injection of epinephrine using an auto-injector device is crucial in managing anaphylaxis and can significantly improve the patient's chances of recovery.

FutureWise Market Research has published a report that provides an insightful analysis of Anaphylaxis Treatment Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Anaphylaxis Treatment Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Impax Laboratories Inc.
  • Lincoln Medical Ltd.
  • Mylan N.V.
  • Adamis Pharmaceutical Corporation
  • MannKind Corporation
  • Pfizer Inc.
  • GlaxoSmithKline Plc.
  • MerckCo., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • ALK-Abelló

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in the Anaphylaxis Treatment Market:

  • During the Annual Conference of the British Society for Allergy and Clinical Immunology (BSACI) in 2021, a significant development took place with the introduction of the UK Anaphylaxis Registry. This pivotal initiative marks a crucial advancement in comprehending anaphylaxis and its impact on individuals within the United Kingdom. By establishing this registry, a foundational stride has been taken towards enhanced insights into allergic reactions, paving the way for potential breakthroughs in anaphylaxis treatment methodologies.

The dynamics shaping the anaphylaxis treatment market are multifaceted and encompass a range of drivers, restraints, and opportunities. One of the primary drivers propelling market growth is the escalating global prevalence of allergy patients. This mounting patient base underpins the increasing demand for effective anaphylaxis treatment solutions. Moreover, strategic advancements and impactful product launches orchestrated by key industry players contribute significantly to the market's expansion, fostering innovation and addressing the unmet medical needs of individuals susceptible to anaphylactic reactions. The infusion of advanced technologies in developing countries presents another avenue for growth. These technologies not only facilitate enhanced treatment options but also extend the reach of anaphylaxis management to regions that previously had limited access to such solutions. The rising trend towards self-administration treatments further stimulates market growth, as patients seek convenient and rapid interventions during allergic emergencies. Research and development endeavors geared towards elevating the quality of anaphylaxis drugs underscore a commitment to efficacy and patient well-being. Such efforts hold the potential to drive improved treatment modalities and redefine the therapeutic landscape for anaphylaxis sufferers.

Despite these drivers, the anaphylaxis treatment market encounters several restraints. Limited awareness and knowledge about anaphylaxis in emerging regions can hinder the adoption of proper treatment protocols, impeding market growth in these areas. Additionally, the adverse effects linked to the usage of steroids and epinephrine present challenges that necessitate careful risk-benefit evaluation when considering treatment options. Comorbidities resulting from associated risk factors such as aging and asthma can exacerbate medical complexities, constraining the market's potential.

By Medication Type

  • Epinephrine
  • Antihistamines
  • Steroids
  • Beta-Agonist
  • H2 blockers
  • Vasodilators
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Others

By Allergy Type

  • Food Allergy
  • Medications
  • Insect Stings
  • Latex Allergy
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Sales
  • Drug Store
  • Mail Order Pharmacies
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. In 2020, North America held the largest share in the anaphylaxis treatment market, with the United States leading within the region. This dominance in the US can be attributed to factors such as convenient access to allergy medications, an increasing occurrence of allergic reactions, and government initiatives facilitating the availability of epinephrine for schoolchildren. Additionally, the prevalence of generic versions of anaphylaxis medicines, coupled with consistent product launches, has notably influenced the epinephrine market in the region. Canada and Mexico are also anticipated to experience market expansion due to a surge in the availability of generic anaphylaxis medications by various industry players. The rising incidence of anaphylactic reactions within these countries further contributes to the projected expansion of the anaphylaxis treatment market throughout the forecast period.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Anaphylaxis Treatment Market By Medication Type, By Route of Administration, By Allergy Type, By Distribution Channel and By Region.
  • To cater comprehensive inRoute of Administrationation on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- Product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Allergy Types
         1.2. Primary Data
          1.1. Key Data from Primary Allergy Types
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Anaphylaxis Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Anaphylaxis Treatment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Anaphylaxis Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Anaphylaxis Treatment Market, By Medication Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Epinephrine
        2. Antihistamines
        3. Steroids
        4. Beta-Agonist
        5. H2 blockers
        6. Vasodilators
        7. Others

  • 8.   Global Anaphylaxis Treatment Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral
        2. Parenteral
        3. Others

  • 9.   Global Anaphylaxis Treatment Market, By Allergy Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Food Allergy
        2. Medications
        3. Insect Stings
        4. Latex Allergy
        5. Others

  • 10.   Global Anaphylaxis Treatment Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital Pharmacies
        2. Retail Sales
        3. Drug Store
        4. Mail Order Pharmacies
        5. Others

  • 11.   North America Anaphylaxis Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Anaphylaxis Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Anaphylaxis Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Anaphylaxis Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Impax Laboratories Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Lincoln Medical Ltd.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Mylan N.V.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Adamis Pharmaceutical Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. MannKind Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Pfizer Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. GlaxoSmithKline Plc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. MerckCo., Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Teva Pharmaceutical Industries Ltd.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. ALK-Abelló
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients